Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms.

[1]  J. Michel,et al.  Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Jialing Wu,et al.  The Interaction between Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and its Receptor Fibroblast Growth Factor-Inducible 14 Promotes the Recruitment of Neutrophils into the Ischemic Brain , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  A. Sanz,et al.  Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[4]  J. Egido,et al.  The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. , 2009, Atherosclerosis.

[5]  N. Bogavac-Stanojević,et al.  Circulating sTWEAK improves the prediction of coronary artery disease. , 2009, Clinical biochemistry.

[6]  J. Winkles.  The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting , 2008, Nature Reviews Drug Discovery.

[7]  Jean-Baptiste Michel,et al.  Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[8]  J. Michel,et al.  Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[9]  A. Ortiz,et al.  Fn14 Is Upregulated in Cytokine-Stimulated Vascular Smooth Muscle Cells and Is Expressed in Human Carotid Atherosclerotic Plaques: Modulation by Atorvastatin , 2006, Stroke.

[10]  J. Michel,et al.  Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. , 2004, The American journal of pathology.

[11]  B. Kwon,et al.  TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[12]  S. Shapiro,et al.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.

[13]  Y. Hsu,et al.  TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis* , 1997, The Journal of Biological Chemistry.

[14]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.